KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $33.0 million.

  • Xylem's Gains from Investment Securities fell 3400.0% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $267.0 million, marking a year-over-year increase of 2594.34%. This contributed to the annual value of $219.0 million for FY2024, which is 379.15% up from last year.
  • Per Xylem's latest filing, its Gains from Investment Securities stood at $33.0 million for Q3 2025, which was down 3400.0% from $138.0 million recorded in Q2 2025.
  • In the past 5 years, Xylem's Gains from Investment Securities ranged from a high of $138.0 million in Q2 2025 and a low of $11.0 million during Q3 2021
  • In the last 5 years, Xylem's Gains from Investment Securities had a median value of $34.0 million in 2022 and averaged $42.7 million.
  • As far as peak fluctuations go, Xylem's Gains from Investment Securities soared by 25000.0% in 2021, and later crashed by 4642.86% in 2022.
  • Over the past 5 years, Xylem's Gains from Investment Securities (Quarter) stood at $12.0 million in 2021, then surged by 183.33% to $34.0 million in 2022, then skyrocketed by 52.94% to $52.0 million in 2023, then grew by 13.46% to $59.0 million in 2024, then crashed by 44.07% to $33.0 million in 2025.
  • Its Gains from Investment Securities was $33.0 million in Q3 2025, compared to $138.0 million in Q2 2025 and $37.0 million in Q1 2025.